Thrombocytopenia at the time of alemtuzumab infusion in relapsing-remitting multiple sclerosis Academic Article uri icon

Overview

MeSH Major

  • Anti-Inflammatory Agents
  • Methylprednisolone
  • Multiple Sclerosis, Relapsing-Remitting
  • Prednisone
  • Recovery of Function

publication date

  • April 2018

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1177/1352458517719152

PubMed ID

  • 28661221

Additional Document Info

start page

  • 553

end page

  • 554

volume

  • 24

number

  • 4